Hemolytic Anemias - Extracorpuscular defects

Slides:



Advertisements
Similar presentations
THE DIRECT ANTIGLOBULIN TEST (DAT) and Elution/Eluate Testing
Advertisements

Hemolytic Disease of the Newborn Case #3
Hemolytic Anemia by Areej T.Kadhum. Haemolysis Normal life span of a RBC is 120 days (80-90 days in a full term infant). Senescent RBC is detected & cleared.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof. Dr Magda Sultan Date : 26/12/2013 Outcome : The student will know : -The types of.
Case #5 Maria De Leon and Melissa Koç Microbiology and Serology; Spring 2010 California State University, Los Angeles.
Antiglobulin Test (Coomb’s Test)
Life of a Red Blood Cell Erythroid precursors undergo 4-5 divisions in marrow, extrude nucleus, become reticulocytes, enter peripheral blood, and survive.
HEMOLYTIC ANEMIAS. HEMOLYTIC ANEMIA Anemia of increased destruction –Normochromic, normochromic anemia –Shortened RBC survival –Reticulocytosis - Response.
Week 2: Hemolytic Anemia
Immuoagglutination test Yasser M. alatawi Pharm.D College of Pharmacy Umm Al-Qura University.
1 BLOOD PHYSIOLOGY Practical 1 BLOOD GROUPS By: khulood Hussein.
Detecting Antibodies The Antibody Screen CLS 422
Practical Blood Bank Anti-Globulin Test Direct, Indirect Lab 5.
Splenectomy in Hematologic Disorders
IMMUNE SYSTEM Biology 2201.
Autoimmune haemolytic anaemia. This results from increased red cell destruction due to red cell autoantibodies. The antibodies may be IgG or M, or more.
Faculty of Allied Medical Science Blood Banking (MLBB 201)
Immunology Chapter 17 Richard L. Myers, Ph.D. Department of Biology Southwest Missouri State Temple Hall 227 Telephone:
Hemolytic Anemias Defined as those anemias result from an increased in the rate of red cell destruction. The red cell destruction is usually removed extravascular.
Lymphoid malignancies. Lymphoproliferative disorders Etiology: Overstimulation Defect of regulation (X-linked lymphoproliferative syndrome) Defects of.
Pages  When blood is given intraveneously  Usually donated blood  Transfusions are given for:  Blood loss due to injury  Surgery  To supplement.
MLAB 1415-Hematology Keri Brophy-Martinez Chapter 14: Introduction to Hemolytic Anemias.
LS/MW MT 417 – Clinical Hematology II Manual/Special Tests Unit Ham’s/Sugar Water/DL Exercise Ham’s/Sugar Water/DL Questions KEY.
Blood Groups & Blood Transfusion
Positive Direct Antiglobulin Test and Autoimmune Hemolytic Anemias Jeffrey S. Jhang, M.D. Assistant Professor of Clinical Pathology College of Physicians.
When can you use an antibody to find another antibody?
Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 2 nd Year – Level 4 – AY Mr. Waggas Ela’as, M.Sc, MLT.
Hemolytic anemia Excessive destruction of red cells Acute Hemolytic anemia Chronic Hemolytic anemia Congenita l Acquired : Immune Non-immune.
Warm Autoimmune Hemolytic Anemia Lisa Rose-Jones, MD Monday, Aug 24th.
___________DEFENSES of the HOST: THE IMMUNE RESPONSE
Laboratory evaluation of erythrocyte RBC Haemoglobin Packed cell volume MCV MCH MCHC RDW Reticulocyte Blood film Quantitative description of erythropoiesis.
Acquired haemolytic anaemias
Auto Immune hemolytic anemia
Hemolytic anemias.
MLAB 1415: Hematology Keri Brophy-Martinez Hemolytic Anemia: Nonimmune Defects.
Acquired Haemolytic Anaemias. Haemolytic conditions are those in which: erythrocyte construction industry is healthy (usually) red cells produced have.
HEMOLYTIC ANEMIAS - EXTRACORPUSCULAR DEFECTS
Dr: Dalia Galal Hamouda
University of Ishik Faculty of dentistry Practical Medical Physiology
R HEUMATOID F ACTOR ( RF ). Rheumatoid arthritis is a chronic inflammatory disorder that affects all joints either in hands or feet and other areas of.
Terry Kotrla, MS, MT(ASCP)BB Unit 13 Investigation of a Positive DAT and Immune Hemolysis.
Immne Hemolytic Aanemia Majid vafaie A number of extrinsic agents and disorders may lead to premature destruction of red blood cells (RBCs) (Table 458-1)
Rh-Blood TYPES. Rh-Blood groups: Rh-Blood groups: The Rh-factor named for the rhesus monkey because it was first studied using the blood of this animal.
Antibody mediated hypersensitivity reaction (type II) PhD. kefah F. hassoon 2014.
MLAB 1415: Hematology Keri Brophy-Martinez Chapter 18: Hemolytic Anemia: Nonimmune Defects.
Lecture 2 blood bank PRINCIPLES OF ANTIGENS AND ANTIBODIES By Dr. Dalia Galal Hamouda.
The complications can be broadly classified into two categories: Immune Complications Non-immune Complications.
Immunity. Body Defenses First line - barriers Skin and mucous membranes Flushing action –Antimicrobial substances Lysozyme, acids, salts, normal microbiota.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives Intoduction Definition Classification Intravascular &extra vascular hemolysis Signs of hemolytic anemias.
MLAB Hematology Keri Brophy-Martinez
Acquired Hemolytic Anemias
Hypersensitivity MBBS- Batch 16 Remya.
By Dr.AMEER E. AL-AASAM. MECHANISM DRUG ADSORPTION (HAPTEN) TERNARY (IMMUNE) COMPLEX AUTOANTIBODY INDUCTION Direct antiglobulin testPositive (anti-IgG)Positive.
Date of download: 7/8/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Effector mechanisms by which drugs mediate a positive direct antiglobulin.
Practical Blood Bank Anti-Globulin Test Direct, Indirect Lab 5.
Practical Blood Bank Lab 5.
Objective 17 Hypersensitivity
Practical Blood Bank Anti-Globulin Test Direct, Indirect Lab 5.
MLAB Hematology Fall 2007 Keri Brophy-Martinez
IMMUNE HEMOLYSIS Definition : red cell life span is shortened because abnormalities in the components of the immune system are specifically directed against.
Immne Hemolytic Aanemia
COOMB’S TECHNIQUES MLS 522.
Russ Morrison November 8, 2006
MLAB Hematology Keri Brophy-Martinez
溶血性贫血 Hemolytic Anemia
MLAB 1415-Hematology Keri Brophy-Martinez
Hypersensitivity reactions
Cold Agglutinin Disease
Cold Agglutinin Screen vs Cold Agglutinin Titer
Approach to Haemolysis
Presentation transcript:

Hemolytic Anemias - Extracorpuscular defects What is destroying this RBC?

Extracorpuscular defects Immune hemolytic anemias These anemias result from a shortened RBC survival mediated by the immune response, specifically humoral antibodies. There are three broad categories: Alloimmune in which the patient produces alloantibodies to foreign RBC antigens introduced through transfusion or pregnancy Transfusion reaction An immediate transfusion reaction is characterized by acute intravascular hemolysis, mostly associated with ABO IgM isoantibodies. The patient’s antibodies destroy the donor’s cells.

RESULTS OF INTRAVASCULAR HEMOLYSIS

Extracorpuscular defects A delayed transfusion reaction occurs 2-14 days after transfusion and usually is the result of an anamnestic response in which IgG antibodies are made in an individual who has been previously sensitized. Extravascular hemolysis of IgG coated antibodies occurs in the spleen. Hemolytic disease of the newborn RBCs of the fetus are destroyed by maternal IgG antibodies that cross the placenta. The baby is often born jaundiced, anemic and with hepatosplenomegaly.

Extravascular hemolysis

Extracorpuscular defects Autoimmune hemolytic anemia – This represents an abnormality in which the immune system’s ability for self-recognition is lost and antibodies are made to the RBC antigens (autoantibodies). They bind to the RBCs and initiate hemolysis. Warm autoimmune hemolytic anemia - In this type of immune hemolytic anemia the serologic reactivity of the IgG antibody involved is optimal at 370 C.  Primary, idiopathic - severe, but self-limiting anemias that may last several weeks to years.       Secondary – associated with some underlying disease (lymphoproliferative, neoplastic, SLE, RA, viral or bacterial infection, chronic inflammatory disease)

Extracorpuscular defects In both the primary and secondary form of the disease, most hemolysis is extravascular and complement is not necessary for cell destruction, though it may be involved (Ag-Ab complexes may be pitted from the cell membrane in the spleen or the cell itself may be ingested by phagocytic cells). The anemia is moderate to severe, the RBCs are normochromic, normocytic with polychromasia (increased reticulocytes). Spherocytes, schistocytes, etc. may be seen and are indicative of the hemolytic process.

Extracorpuscular defects The direct Coombs test is positive. This tests for RBCs sensitized with IgG Ab or complement. IgM antibodies will agglutinate RBCs in saline, but IgG antibodies are not large enough to overcome the zeta potential of the RBCs. In the direct Coombs test, antihuman globulin (AHG), which contains antibodies to human antibodies and complement, is added to cells suspected of having IgG or complement bound to them. When AHG binds to the IgG or complement that is bound to RBCs, it bridges the distance between the RBCs which leads to agglutination and a positive test. Treatment is glucocorticoids, splenectomy, or other immunosuppressive drugs.

Zeta potential

Warm autoimmune hemolytic anemia

Extracorpuscular defects Cold autoimmune hemolytic anemia – pathologic cold autoantibodies are usually IgM antibodies that fix complement and are optimally reactive below 370 C. It is normal to have benign cold autoantibodies, but their thermal amplitude and concentration are not high enough to cause problems. The pathologic forms can be divided into three types:       Cold agglutinin syndrome – This is idiopathic, chronic, usually in individuals older than 50, and usually due to an IgM monoclonal antibody. Secondary, cold autoimmune hemolytic anemia – due to polyclonal IgM antibodies that develop with Mycoplasma pneumonia infections, infectious mononucleosis, or lymphoproliferative disease. Is usually transient.

COLD AGGLUTININ

Extracorpuscular defects In both a and b the extent of the disease is related to the thermal amplitude of the antibody – if it reacts at 30-320 C, it can cause problems when the peripheral circulation cools to that temperature: IgM binds and fixes complement, upon warming the antibody dissociates, but complement remains bound leading to either intravascular or extravascular hemolysis. The patient may experience acrocyanosis of hands, feet, ears, and nose (with agglutination blood flow slows down, the skin turns white and then blue; upon warming, the skin turns red). Blood counts are difficult to perform unless the blood is warmed. The Coombs test with anti-complement antibody is positive.

Extracorpuscular defects The cold agglutinin test is positive at 0-200 C and usually up to 300 C. The titer is usually 1:1000 or greater. Paroxysmal cold hemoglobinuria (the third type of cold autoimmune hemolytic anemia) – is found in association with viral disorders and syphilis and may be chronic. This is characterized by massive, intermittent, acute intravascular hemolysis and hemoglobinuria upon exposure to cold. It is caused by a biphasic IgG antibody that binds at low temperature and fixes complement. Upon warming, to body temperature, the intravascular hemolysis occurs and is accompanied by fever, shaking chills, and abdominal and back cramps.           

Cold autoimmunne hemolytic anemia

Extracorpuscular defects Drug induced immune hemolytic anemia – many different drugs can cause this and 3-4 different mechanisms may be involved.                 Immune complex mechanism The drug binds to plasma proteins and antibodies are made against the drug. The antibodies bind to the drug to form an immune complex which adsorbs nonspecifically to the patients RBCs, complement is fixed, and acute intravascular hemolysis occurs.

IMMUNE COMPLEX MECHANISM

Extracorpuscular defects Drug adsorption (hapten) mechanism The drug binds nonspecifically to proteins on the RBC membrane, antibodies are made (usually IgG), they bind to the drug and extravascular hemolysis occurs. Membrane modification mechanism The drug modifies the RBC membrane so that normal plasma proteins bind nonimmunologically. In rare instances a cross reacting antibody causes a hemolytic anemia. Methyldopa induced mechanism The drug induces formation of autoantibodies causing extravascular destruction. It may change autoproteins so that they are no longer recognized as self, or it may cause a direct loss of T suppressor cells.

DRUG ADSORPTION

MEMBRANE MODIFICATION

Extracorpuscular defects Nonimmune hemolytic anemias Caused by antagonists in blood or abnormalities in plasma lipids.   Chemicals and drugs Include drugs that cause oxidative injury Inhalation of arsine gas Lead intoxication (in addition to interfering with heme synthesis, lead can cause membrane damage by interfering with energy production) Injection of large volumes of water. Animal venoms – bees, wasps, spiders, scorpions in susceptible individuals, rarely snakebites Infectious agents – malarial parasites, Babeiosis, Clostridium perfringens, Bartonella bacilliformis

BABEIOSIS AND MALARIA

Extracorpuscular defects Abnormal plasma lipid composition – note that these were also included in intracorpuscular problems, because they lead to intrinsic problems with the RBC. Spur cell anemia – associated with severe hepatocellular disease which leads to increased serum lipoproteins, increased membrane cholesterol, decreased deformability and decreased survival Abetalippoproteinemia – leads to an increased cholesterol/phospholipid ratio, acanthocytes, and decreased RBC survival. Caused by physical injury to RBCs Microangiopathic hemolytic anemia Caused by microcirculatory lesions that cause the RBCs to tear due to sheer stress Disseminated cancer

Spur cell anemia

Extracorpuscular defects Hemolytic uremic syndrome Idiopathic thrombotic thrombocytopenic purpura – microthrombi are deposited in the microvasculature Malignant hypertension Disseminated intravascular coagulation.    Macroangiopathic hemolytic anemia Due to abnormalities in the heart or large vessels causing RBC hemolysis Prosthetic heart valves March hemoglobinemia Transient hemolytic anemia occurring after strenuous exercise with contact with a hard surface (running, marching) Thermal injury

MICROANGIOPTHIC HEMOLYTIC ANEMIA

THERMAL INJURY

Thermal injury